Prof Patrice Lalive
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients (NCT05596526) | Prof Patrice Lalive | 2022-12-01 |
Track Prof Patrice Lalive automatically
Every clearance here is in the API, with alerts when new ones post.